Gilead chooses Roche veteran Daniel O’Day as new CEO
Are device companies still interested in M&A?
Will NASDAQ’s record IPO success continue?
5 top drug/biotech M&A candidates
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*